dc.contributor.author | Borman, Pinar | |
dc.contributor.author | Demir, Gülseren | |
dc.contributor.author | Kaygısız, Ferda | |
dc.contributor.author | Okumuş, Muyesser | |
dc.date.accessioned | 2019-12-10T10:53:21Z | |
dc.date.available | 2019-12-10T10:53:21Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | https://doi.org/10.2174/1874312901408010018 | |
dc.identifier.uri | http://benthamopen.com/ABSTRACT/TORJ-8-18 | |
dc.identifier.uri | http://hdl.handle.net/11655/14614 | |
dc.language.iso | en | |
dc.relation.isversionof | 10.2174/1874312901408010018 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Letter To The Editor: Subcutaneous (Sc) Methotrexate (Mtx) Is Better And Well-Tolerable Than Oral Mtx In Rheumatoid Arthritis Patients, Switched From Oral To Sc Administration Due To Gastrointestinal Side Effects | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | The Open Rheumatology Journal | |
dc.contributor.department | Fiziksel Tıp ve Rehabilitasyon | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 18 | |
dc.identifier.endpage | 19 | |
dc.description.index | PubMed | |